Bausch & Lomb Corp. (BLCO) fundamentals score
Bausch + Lomb Corporation (and its subsidiaries) is dedicated to protecting and enhancing the gift of sight for millions of people around the world – from the moment of birth through every phase of life. Its mission is simple, yet powerful: helping you see better, to live better.
Ophthalmic Goods · Healthcare · Listed on NYSE
Overall: 5.5 out of 10, Mixed fundamentals
- Growth: 4.9/10
- Profitability: 5.0/10
- Financial health: 3.0/10
- Earnings quality: 8.7/10
- Valuation: 7.3/10
Scores are calculated from Bausch & Lomb Corp.’s SEC filings, using the 12 months through 2026-06. Compare it with past big winners, check its flags, and see today’s price against its fundamentals in the full scorecard.
Other Healthcare stocks
- Nurix Therapeutics, Inc. (NRIX): 9.0/10
- Caredx, Inc. (CDNA): 8.9/10
- Dexcom, Inc. (DXCM): 8.8/10
- Exelixis Inc. (EXEL): 8.8/10
- Neurocrine Biosciences Inc. (NBIX): 8.7/10
- Progyny, Inc. (PGNY): 8.6/10
- Healthcare Services Group, Inc. (HCSG): 8.5/10
- Insulet Corporation (PODD): 8.5/10